{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:24:38Z","timestamp":1791815078777,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["No.82203726"],"award-info":[{"award-number":["No.82203726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02193-5","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:40:16Z","timestamp":1780299616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exosomal integrin \u03b1v\u03b23 derived from colorectal cancer promotes the liver pre-metastatic niche formation by inducing cancer-associated fibroblasts activation"],"prefix":"10.1007","volume":"26","author":[{"given":"Jing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinXiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"2193_CR1","doi-asserted-by":"publisher","unstructured":"Underwood PW, Ruff SM, Pawlik TM Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer [J]. Cells. 2024;13(3). . https:\/\/doi.org\/10.3390\/cells13030245.","DOI":"10.3390\/cells13030245"},{"issue":"9","key":"2193_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Ca\u00f1ellas-socias","year":"2024","unstructured":"Ca\u00f1ellas-socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21(9):609\u201325. https:\/\/doi.org\/10.1038\/s41575-024-00934-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10207","key":"2193_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)32319-0.","journal-title":"Lancet"},{"issue":"5","key":"2193_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336. https:\/\/doi.org\/10.3322\/caac.21731.","journal-title":"CA Cancer J Clin"},{"key":"2193_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/clep.S34285","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors [J]. Clin Epidemiol. 2012;4:283\u2013301. https:\/\/doi.org\/10.2147\/clep.S34285.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"2193_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/02656736.2018.1528511","volume":"36","author":"S Qin","year":"2019","unstructured":"Qin S, Liu GJ, Huang M, et al. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center. Int J Hyperthermia. 2019;36(1):36\u201343. https:\/\/doi.org\/10.1080\/02656736.2018.1528511.","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"2193_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00104-020-01233-4","volume":"91","author":"A Ali Deeb","year":"2020","unstructured":"Ali Deeb A, Ardelt M, Settmacher U. [The role of liver transplantation in nonresectable colorectal liver metastases]. Chirurg. 2020;91(8):678. https:\/\/doi.org\/10.1007\/s00104-020-01233-4.","journal-title":"Chirurg"},{"issue":"4","key":"2193_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1457496918766706","volume":"107","author":"A Nor\u00e9n","year":"2018","unstructured":"Nor\u00e9n A, Sandstr\u00f6m P, Gunnarsdottir K, et al. Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden. Scand J Surg. 2018;107(4):294\u2013301. https:\/\/doi.org\/10.1177\/1457496918766706.","journal-title":"Scand J Surg"},{"issue":"9","key":"2193_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","volume":"55","author":"CL Stewart","year":"2018","unstructured":"Stewart CL, Warner S, Ito K, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330\u201379. https:\/\/doi.org\/10.1067\/j.cpsurg.2018.08.004.","journal-title":"Curr Probl Surg"},{"issue":"6","key":"2193_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/sla.0000000000002552","volume":"267","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis. Ann Surg. 2018;267(6):1047\u201355. https:\/\/doi.org\/10.1097\/sla.0000000000002552.","journal-title":"Ann Surg"},{"issue":"8","key":"2193_CR11","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1002\/cam4.5732","volume":"12","author":"YM Su","year":"2023","unstructured":"Su YM, Liu W, Yan XL, et al. Five-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: recurrence patterns and prediction for potential cure. Cancer Med. 2023;12(8):9559\u201369. https:\/\/doi.org\/10.1002\/cam4.5732.","journal-title":"Cancer Med"},{"key":"2193_CR12","doi-asserted-by":"publisher","unstructured":"Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival [J]. Ann Surg. 2004;240(4). https:\/\/doi.org\/10.1097\/01.sla.0000141198.92114.f6. 644\u2009\u2013\u200957; discussion 57\u2009\u2013\u20098.","DOI":"10.1097\/01.sla.0000141198.92114.f6"},{"issue":"34","key":"2193_CR13","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1200\/jco.21.01032","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shimizu Y, Mizusawa J, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789\u201399. https:\/\/doi.org\/10.1200\/jco.21.01032.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2193_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003.","journal-title":"Trends Pharmacol Sci"},{"key":"2193_CR15","doi-asserted-by":"publisher","unstructured":"Gumberger P, Bjornsson B, Sandstr\u00f6m P, et al The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention [J]. Cancers (Basel). 2022;14(12). . https:\/\/doi.org\/10.3390\/cancers14123028.","DOI":"10.3390\/cancers14123028"},{"issue":"3","key":"2193_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, et al. Immune determinants of the pre-metastatic niche. Cancer Cell. 2023;41(3):546\u201372. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.018.","journal-title":"Cancer Cell"},{"issue":"1","key":"2193_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1019-x","volume":"18","author":"JL Hu","year":"2019","unstructured":"Hu JL, Wang W, Lan XL, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18(1):91. https:\/\/doi.org\/10.1186\/s12943-019-1019-x.","journal-title":"Mol Cancer"},{"key":"2193_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.655152","volume":"9","author":"X Geng","year":"2021","unstructured":"Geng X, Chen H, Zhao L, et al. Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer. Front Cell Dev Biol. 2021;9:655152. https:\/\/doi.org\/10.3389\/fcell.2021.655152.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"2193_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, Mcandrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792\u2013804. https:\/\/doi.org\/10.1038\/s41571-021-00546-5.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2193_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02583-0","volume":"9","author":"T FAng","year":"2018","unstructured":"FAng T, Lv H, Lv G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9(1):191. https:\/\/doi.org\/10.1038\/s41467-017-02583-0.","journal-title":"Nat Commun"},{"issue":"1","key":"2193_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"issue":"5","key":"2193_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","volume":"24","author":"S Kamali Zonouzi","year":"2022","unstructured":"Kamali Zonouzi S, Pezeshki PS, Razi S, et al. Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol. 2022;24(5):757\u201369. https:\/\/doi.org\/10.1007\/s12094-021-02734-2.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"2193_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2193_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.imlet.2017.06.009","volume":"188","author":"YX Xie","year":"2017","unstructured":"Xie YX, Liao R, Pan L, et al. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma. Immunol Lett. 2017;188:116\u201323. https:\/\/doi.org\/10.1016\/j.imlet.2017.06.009.","journal-title":"Immunol Lett"},{"issue":"4","key":"2193_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/cs20110002","volume":"121","author":"A Santamato","year":"2011","unstructured":"Santamato A, Fransvea E, Dituri F, et al. Hepatic stellate cells stimulate HCC cell migration via laminin-5 production. Clin Sci (Lond). 2011;121(4):159\u201368. https:\/\/doi.org\/10.1042\/cs20110002.","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"2193_CR26","doi-asserted-by":"publisher","first-page":"G749","DOI":"10.1152\/ajpgi.00138.2014","volume":"307","author":"C Liu","year":"2014","unstructured":"Liu C, Li J, Xiang X, et al. PDGF receptor-\u03b1 promotes TGF-\u03b2 signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-\u03b2 receptors. Am J Physiol Gastrointest Liver Physiol. 2014;307(7):G749-59. https:\/\/doi.org\/10.1152\/ajpgi.00138.2014.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"2193_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04317-0","volume":"7","author":"XK Zhao","year":"2017","unstructured":"Zhao XK, Yu L, Cheng ML, et al. Focal adhesion kinase regulates hepatic stellate cell activation and liver fibrosis. Sci Rep. 2017;7(1):4032. https:\/\/doi.org\/10.1038\/s41598-017-04317-0.","journal-title":"Sci Rep"},{"issue":"2","key":"2193_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/hep4.1452","volume":"4","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li Q, Tu K, et al. Focal adhesion kinase promotes hepatic stellate cell activation by regulating plasma membrane localization of TGF\u03b2 receptor 2. Hepatol Commun. 2020;4(2):268\u201383. https:\/\/doi.org\/10.1002\/hep4.1452.","journal-title":"Hepatol Commun"},{"issue":"5","key":"2193_CR29","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/hep.24562","volume":"54","author":"YL Jia","year":"2011","unstructured":"Jia YL, Shi L, Zhou JN, et al. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase\/extracellular signal-regulated kinase\/matrix metalloproteinase-9 axis. Hepatology. 2011;54(5):1808\u201318. https:\/\/doi.org\/10.1002\/hep.24562.","journal-title":"Hepatology"},{"issue":"3","key":"2193_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.12182\/20230560301","volume":"54","author":"B Jin","year":"2023","unstructured":"Jin B, Zhang YY, Pan JX. [The role and significance of hepatic environmental cells in tumor metastatic colonization to liver]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54(3):469\u201374. https:\/\/doi.org\/10.12182\/20230560301.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"2193_CR31","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.2147\/cmar.S259125","volume":"12","author":"F Tan","year":"2020","unstructured":"Tan F, He D, Hu K, et al. WAVE2 enhanced hepatic stellate cells activity in colorectal liver metastases. Cancer Manag Res. 2020;12:7671\u201380. https:\/\/doi.org\/10.2147\/cmar.S259125.","journal-title":"Cancer Manag Res"},{"key":"2193_CR32","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.2147\/ott.S214409","volume":"12","author":"WH Huang","year":"2019","unstructured":"Huang WH, Zhou MW, Zhu YF, et al. The role of hepatic stellate cells in promoting liver metastasis of colorectal carcinoma. Onco Targets Ther. 2019;12:7573\u201380. https:\/\/doi.org\/10.2147\/ott.S214409.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"2193_CR33","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino A, Kim HS, Bojmar L, et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell. 2020;182(4):1044-61.e18. https:\/\/doi.org\/10.1016\/j.cell.2020.07.009.","journal-title":"Cell"},{"issue":"10","key":"2193_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","volume":"15","author":"R Xu","year":"2018","unstructured":"Xu R, Rai A, Chen M, et al. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617\u201338. https:\/\/doi.org\/10.1038\/s41571-018-0036-9.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2193_CR35","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.009.","journal-title":"Cancer Cell"},{"key":"2193_CR36","doi-asserted-by":"publisher","unstructured":"Kalluri R, Lebleu VS. The biology, function, and biomedical applications of exosomes [J]. Science. 2020;367(6478). https:\/\/doi.org\/10.1126\/science.aau6977.","DOI":"10.1126\/science.aau6977"},{"key":"2193_CR37","doi-asserted-by":"publisher","unstructured":"Gu WJ, Shen YW, Zhang LJ et al. The multifaceted involvement of exosomes in tumor progression: Induction and inhibition [J]. MedComm (2020), 2021, 2(3): 297\u2013314.https:\/\/doi.org\/10.1002\/mco2.49","DOI":"10.1002\/mco2.49"},{"issue":"7578","key":"2193_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329\u201335. https:\/\/doi.org\/10.1038\/nature15756.","journal-title":"Nature"},{"issue":"1","key":"2193_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14869-x","volume":"11","author":"Q Ji","year":"2020","unstructured":"Ji Q, Zhou L, Sui H, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation. Nat Commun. 2020;11(1):1211. https:\/\/doi.org\/10.1038\/s41467-020-14869-x.","journal-title":"Nat Commun"},{"issue":"2","key":"2193_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/cr.2015.153","volume":"26","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X. Organotropic metastasis: role of tumor exosomes. Cell Res. 2016;26(2):149\u201350. https:\/\/doi.org\/10.1038\/cr.2015.153.","journal-title":"Cell Res"},{"issue":"10","key":"2193_CR41","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1111\/jth.15440","volume":"19","author":"BK Sharma","year":"2021","unstructured":"Sharma BK, Mureb D, Murab S, et al. Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth. J Thromb Haemost. 2021;19(10):2480\u201394. https:\/\/doi.org\/10.1111\/jth.15440.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2193_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.7150\/thno.22601","volume":"8","author":"J Zhang","year":"2018","unstructured":"Zhang J, Mao F, Niu G, et al. (68)Ga-BBN-RGD PET\/CT for GRPR and integrin \u03b1v\u03b23 imaging in patients with breast cancer. Theranostics. 2018;8(4):1121\u201330. https:\/\/doi.org\/10.7150\/thno.22601.","journal-title":"Theranostics"},{"issue":"1","key":"2193_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01236-z","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, Sun X, Gu Y, et al. Discovery of C19-9 as a novel non-RGD inhibitor of \u03b1v\u03b23 to overcome enzalutamide resistance in castration-resistant prostate cancer. Signal Transduct Target Ther. 2023;8(1):60. https:\/\/doi.org\/10.1038\/s41392-022-01236-z.","journal-title":"Signal Transduct Target Ther"},{"key":"2193_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","volume":"528","author":"P Nan","year":"2022","unstructured":"Nan P, Dong X, Bai X, et al. Tumor-stroma TGF-\u03b21-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1v\u03b23\/CD36-mediated activation of the MAPK pathway. Cancer Lett. 2022;528:59\u201375. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.025.","journal-title":"Cancer Lett"},{"issue":"20","key":"2193_CR45","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.7150\/jca.26740","volume":"10","author":"TJ Pan","year":"2019","unstructured":"Pan TJ, Li LX, Zhang JW, et al. Antimetastatic Effect of Fucoidan-Sargassum against Liver Cancer Cell Invadopodia Formation via Targeting Integrin \u03b1V\u03b23 and Mediating \u03b1V\u03b23\/Src\/E2F1 Signaling [J]. J Cancer. 2019;10(20):4777\u201392. https:\/\/doi.org\/10.7150\/jca.26740.","journal-title":"J Cancer"},{"key":"2193_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2016.07.008","volume":"42","author":"F Demircioglu","year":"2016","unstructured":"Demircioglu F, Hodivala-Dilke K. \u03b1v\u03b23 Integrin and tumour blood vessels-learning from the past to shape the future [J]. Curr Opin Cell Biol. 2016;42:121\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2016.07.008.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"2193_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","volume":"37","author":"J Luo","year":"2018","unstructured":"Luo J, Yao JF, Deng XF, et al. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling [J]. J Exp Clin Cancer Res. 2018;37(1):23. https:\/\/doi.org\/10.1186\/s13046-018-0694-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2193_CR48","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1158\/1541-7786.Mcr-16-0447","volume":"15","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Dai J, Yao Z, et al. Abituzumab Targeting of \u03b1V-Class Integrins Inhibits Prostate Cancer Progression [J]. Mol Cancer Res. 2017;15(7):875\u201383. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-16-0447.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"2193_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13046-019-1455-x","volume":"38","author":"F Sun","year":"2019","unstructured":"Sun F, Wang J, Sun Q, et al. Interleukin-8 promotes integrin \u03b23 upregulation and cell invasion through PI3K\/Akt pathway in hepatocellular carcinoma [J]. J Exp Clin Cancer Res. 2019;38(1):449. https:\/\/doi.org\/10.1186\/s13046-019-1455-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"2193_CR50","doi-asserted-by":"publisher","unstructured":"Pang XJ, Liu XJ, Liu Y, et al. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy [J]. Molecules. 2021;26(14). https:\/\/doi.org\/10.3390\/molecules26144250.","DOI":"10.3390\/molecules26144250"},{"issue":"9","key":"2193_CR51","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.celrep.2019.07.092","volume":"28","author":"P Bordignon","year":"2019","unstructured":"Bordignon P, Bottoni G, XU X, et al. Dualism of FGF and TGF-\u03b2 Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant [J]. Cell Rep. 2019;28(9):2358\u201372. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.092.","journal-title":"Cell Rep"},{"issue":"13","key":"2193_CR52","first-page":"3103","volume":"56","author":"Z Yun","year":"1996","unstructured":"Yun Z, Menter DG, Nicolson GL. Involvement of integrin alphavbeta3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma [J]. Cancer Res. 1996;56(13):3103\u201311.","journal-title":"Cancer Res"},{"issue":"5957","key":"2193_CR53","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO. The extracellular matrix: not just pretty fibrils [J]. Science. 2009;326(5957):1216. https:\/\/doi.org\/10.1126\/science.1176009.","journal-title":"Science"},{"issue":"4","key":"2193_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nsmb.2797","volume":"21","author":"JF Van Agthoven","year":"2014","unstructured":"Van Agthoven JF, Xiong JP, Alonso JL, et al. Structural basis for pure antagonism of integrin \u03b1V\u03b23 by a high-affinity form of fibronectin. Nat Struct Mol Biol. 2014;21(4):383\u20138. https:\/\/doi.org\/10.1038\/nsmb.2797.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"2193_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9\u201322. https:\/\/doi.org\/10.1038\/nrc2748.","journal-title":"Nat Rev Cancer"},{"key":"2193_CR56","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.003","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Gastroenterology. 2008;134(6):1655\u201369. https:\/\/doi.org\/10.1053\/j.gastro.2008.03.003. Mechanisms of hepatic fibrogenesis [J]."},{"issue":"4","key":"2193_CR57","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s12253-020-00805-3","volume":"26","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhang L, Wang Q, et al. Comparison of different colorectal cancer with liver metastases models using six colorectal cancer cell lines. Pathol Oncol Res. 2020;26(4):2177\u201383. https:\/\/doi.org\/10.1007\/s12253-020-00805-3.","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"2193_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/hep.0000000000000763","volume":"80","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang X, Bai B, et al. Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology. 2024;80(3):578\u201394. https:\/\/doi.org\/10.1097\/hep.0000000000000763.","journal-title":"Hepatology"},{"issue":"1","key":"2193_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, et al. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114(1):16\u201324. https:\/\/doi.org\/10.1111\/cas.15609.","journal-title":"Cancer Sci"},{"key":"2193_CR60","doi-asserted-by":"publisher","unstructured":"Pomella S, Cassandri M, Braghini MR, et al. New Insights on the Nuclear Functions and Targeting of FAK in Cancer [J]. Int J Mol Sci. 2022;23(4). https:\/\/doi.org\/10.3390\/ijms23041998.","DOI":"10.3390\/ijms23041998"},{"issue":"1","key":"2193_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-020-00022-z","volume":"2","author":"H Wang","year":"2021","unstructured":"Wang H, Pan J, Barsky L, et al. Characteristics of pre-metastatic niche: The landscape of molecular and cellular pathways. Mol Biomed. 2021;2(1):3. https:\/\/doi.org\/10.1186\/s43556-020-00022-z.","journal-title":"Mol Biomed"},{"issue":"5","key":"2193_CR62","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jcmgh.2024.01.013","volume":"17","author":"S Abudukelimu","year":"2024","unstructured":"Abudukelimu S, De Miranda N, Hawinkels L. Fibroblasts in orchestrating colorectal tumorigenesis and progression. Cell Mol Gastroenterol Hepatol. 2024;17(5):821\u20136. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.01.013.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"2193_CR63","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/path.5618","volume":"253","author":"N Nishimichi","year":"2021","unstructured":"Nishimichi N, Tsujino K, Kanno K, et al. Induced hepatic stellate cell integrin, \u03b18\u03b21, enhances cellular contractility and TGF\u03b2 activity in liver fibrosis. J Pathol. 2021;253(4):366\u201373. https:\/\/doi.org\/10.1002\/path.5618.","journal-title":"J Pathol"},{"key":"2193_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu F, Wu Q, Dong Z, et al. Integrins in cancer: emerging mechanisms and therapeutic opportunities. Pharmacol Ther. 2023;247:108458. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108458.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"2193_CR65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533\u201348. https:\/\/doi.org\/10.1038\/s41568-018-0038-z.","journal-title":"Nat Rev Cancer"},{"key":"2193_CR66","doi-asserted-by":"publisher","unstructured":"Huang L, Wang F, Wang X et al. M2-like macrophage-derived exosomes facilitate metastasis in non-small-cell lung cancer by delivering integrin \u03b1V\u03b23 [J]. MedComm (2020), 2023, 4(1): e191https:\/\/doi.org\/10.1002\/mco2.191","DOI":"10.1002\/mco2.191"},{"issue":"11","key":"2193_CR67","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/1541-7786.Mcr-16-0058","volume":"14","author":"A Singh","year":"2016","unstructured":"Singh A, Fedele C, Lu H, et al. Exosome-mediated transfer of \u03b1v\u03b23 integrin from tumorigenic to nontumorigenic cells promotes a migratory phenotype. Mol Cancer Res. 2016;14(11):1136\u201346. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-16-0058.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"2193_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1023\/a:1021356019563","volume":"19","author":"H Kikkawa","year":"2002","unstructured":"Kikkawa H, Kaihou M, Horaguchi N, et al. Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses [J]. Clin Exp Metastasis. 2002;19(8):717\u201325. https:\/\/doi.org\/10.1023\/a:1021356019563.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"2193_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12186","volume":"11","author":"S Zhao","year":"2022","unstructured":"Zhao S, Mi Y, Zheng B, et al. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. J Extracell Vesicles. 2022;11(1):e12186. https:\/\/doi.org\/10.1002\/jev2.12186.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2193_CR70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, et al. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237\u201355. https:\/\/doi.org\/10.7150\/thno.21945.","journal-title":"Theranostics"},{"key":"2193_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.12.003","volume":"343","author":"Z Liao","year":"2019","unstructured":"Liao Z, Tan ZW, Zhu P, et al. Cancer-associated fibroblasts in tumor microenvironment - accomplices in tumor malignancy. Cell Immunol. 2019;343:103729. https:\/\/doi.org\/10.1016\/j.cellimm.2017.12.003.","journal-title":"Cell Immunol"},{"issue":"3","key":"2193_CR72","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/15384047.2019.1685157","volume":"21","author":"HX Tan","year":"2020","unstructured":"Tan HX, Gong WZ, Zhou K, et al. CXCR4\/TGF-\u03b21 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer. Cancer Biol Ther. 2020;21(3):258\u201368. https:\/\/doi.org\/10.1080\/15384047.2019.1685157.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"2193_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04506-4","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wang XY, Zhang P, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis. 2022;13(1):57. https:\/\/doi.org\/10.1038\/s41419-022-04506-4.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2193_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Xia X, Huang LB, et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619. https:\/\/doi.org\/10.1038\/s41467-022-34395-2.","journal-title":"Nat Commun"},{"key":"2193_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1375543","volume":"12","author":"J Yin","year":"2024","unstructured":"Yin J, Zhu W, Feng S, et al. The role of cancer-associated fibroblasts in the invasion and metastasis of colorectal cancer. Front Cell Dev Biol. 2024;12:1375543. https:\/\/doi.org\/10.3389\/fcell.2024.1375543.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2193_CR76","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.apsb.2021.01.004","volume":"11","author":"M Li","year":"2021","unstructured":"Li M, Wang Y, Li M, et al. Integrins as attractive targets for cancer therapeutics. Acta Pharm Sin B. 2021;11(9):2726\u201337. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.004.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"2193_CR77","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.ijrobp.2006.04.036","volume":"65","author":"JM Albert","year":"2006","unstructured":"Albert JM, Cao C, Geng L, et al. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models [J]. Int J Radiat Oncol Biol Phys. 2006;65(5):1536\u201343. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.036.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02193-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:28:45Z","timestamp":1785806925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02193-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2193"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02193-5","relation":{"references":[{"id-type":"doi","id":"10.1053\/j.gastro.2008.03.003","asserted-by":"subject"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki principles. This study was approved by the Ethics Committee of Beijing Friendship Hospital affiliated to Capital Medical University (Approval No. 2025-P2-089-01).","order":2,"name":"Ethics","label":"Ethic approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have consented to the publication of this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"286"}}